Overview

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141

Status:
Completed
Trial end date:
2018-02-25
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess the safety and efficacy of Lumason-enhanced dobutamine stress echo (CE-DSE) in subjects having a suboptimal left ventricular endocardial border delineation (LV EBD) at rest and who were scheduled for coronary angiography.
Phase:
Phase 3
Details
Lead Sponsor:
Bracco Diagnostics, Inc
Treatments:
Dobutamine